Connect with us

News

What we know about BA.2 — now the dominant cause of Covid-19 in the US | CNN

Published

on

What we know about BA.2 — now the dominant cause of Covid-19 in the US | CNN



CNN
 — 

The extremely contagious Omicron subvariant BA.2 is now the dominant coronavirus pressure in the US, inflicting greater than half of all Covid-19 infections final week, the US Facilities for Illness Management and Prevention stated Tuesday.

The brand new numbers come from the CDC’s genomic surveillance. Primarily based on its fashions, the company says that BA.2 brought on between 51% and 59% of all new Covid-19 infections within the US the week ending March 26, up from an estimated 39% of all new infections the week earlier than.

The toughest-hit area was the Northeast, the place BA.2 brought on greater than 70% of all circumstances. The South and Mountain West noticed the fewest circumstances. BA.2 brought on barely greater than one-third of infections in these areas final week.

Advertisement

Although BA.2 continues to be simply taking the stage within the US, it has had outstanding runs in lots of different elements of the world, together with Southeast Asia and the Western Pacific, and is winding down its European tour.

In response to the World Well being Group, BA.2 can be the principle explanation for Covid-19 globally, out-muscling two different Omicron lineages, BA.1 and BA 1.1, to change into the dominant pressure. Since its takeover, worldwide case counts – which had been declining because the first week of January – have been rising once more.

Within the UK, which has a extra extremely vaccinated inhabitants than the US, a mix of lifted restrictions, waning immunity and an much more contagious model of the virus have created a brand new BA.2 wave. Covid-19 circumstances, hospitalizations and deaths have been trending upward because the finish of February, and now, the weekly common of recent circumstances stands about the place it was on the finish of January.

BA.2 infections haven’t reached the peaks seen with BA.1, nonetheless. Case counts seem like leveling off within the UK, although hospitalizations and deaths are nonetheless rising.

All through the pandemic, the US has adopted the UK by about three weeks, so when circumstances started rising there, well being officers right here took discover.

Advertisement

In America, BA.2 has been gaining steam because the finish of January, and case numbers have plateaued. That flattening conceals regional variations, nonetheless. In 13 states, weekly common numbers of recent circumstances are rising, they usually have stopped falling in 14 others, in line with knowledge collected by Johns Hopkins College.

It’s nonetheless not clear what this subvariant will do within the US. Even specialists don’t precisely know what to anticipate.

“We’re not immune from what occurs in Europe,” stated former CDC Director Dr. Tom Frieden, who’s now president and CEO of the nonprofit Resolve to Save Lives.

“In Europe, you see BA.2 turning into predominant and driving a resurgence, and the probability that won’t occur within the US is fairly low, actually,” Frieden stated. “I do assume a part of the explanation that we’re plateauing is that we’re about to start out going up once more.”

Frieden doesn’t assume it’s a coincidence that the US Meals and Drug Administration approved further booster photographs for Individuals who’re 50 and older on Tuesday, the identical day the CDC estimated that BA.2 was dominant.

Advertisement

Nevertheless it’s anybody’s guess how excessive circumstances will go, whether or not numerous individuals will want hospital care, and whether or not the nation will proceed to see breathtaking numbers of deaths.

Most predictions about BA.2 within the US haven’t been dire.

The College of Washington’s Institute for Well being Metrics and Analysis’s Covid-19 projections, up to date final week, predict that BA.2 won’t drive one other surge within the US.

However they are saying we might even see one thing like what occurred in South Africa, the place BA.2 quietly changed its cousin BA.1 as the principle explanation for Covid-19 infections – with no rise in circumstances or deaths. As a substitute, it drew out Omicron’s descent, inflicting a protracted tail.

Michael Osterholm, who directs the College of Minnesota’s Heart for Infectious Illness Analysis and Coverage, known as the coronavirus ready recreation we play each few months “a well-recognized uncertainty.” He devoted his newest podcast to “all of us who stay confused about what the quick or intermediate future appears to be like like with Covid.”

Advertisement

There are a number of the explanation why it’s exhausting to know what BA.2 could do. The CDC estimates that 37 million Individuals – about 1 in 11 – received Covid-19 over the winter, in the course of the first Omicron wave. Many extra have immunity from vaccination and boosters. So, primarily based on random blood samples, the CDC says that 95% of Individuals could now have a point of immunity from Covid-19.

Dr. Jorge Salinas, an infectious illness professional at Stanford College, calls this an immunologic wall.

“That provides us some safety towards future surges,” he stated. “Nonetheless, that wall deteriorates with time. The longer it goes after a wave or after vaccination, the larger the decay of the wall.”

Research have decided decided that BA.2 evades our vaccinations about in addition to unique Omicron did, so boosters are wanted to revive protections towards these variants. However lower than half the US inhabitants 12 and older has had a beneficial third dose.

Of best concern are adults over 65, as a result of they’re principally more likely to change into severely unwell with Covid-19. One out of three individuals over 65 within the US hasn’t had a essential third vaccine dose.

Advertisement

“The actual downside is that a lot of our inhabitants is undervaccinated seniors,” Frieden stated. “That’s our Achilles heel.”

The opposite variable is discovered within the virus itself.

Omicron threw our immune defenses for a loop. It was so totally different from the coronavirus strains that got here earlier than that many individuals who’d gotten sick with Delta or different early strains discovered themselves contaminated once more.

BA.2 has about 40 amino acid adjustments from Omicron’s BA.1, making it about as totally different from its cousin as Alpha, Beta and Delta had been from one another. Some have questioned whether or not BA.2 might reinfect individuals who’d had BA.1.

A big research from Denmark means that these sorts of reinfections are doable however uncommon.

Advertisement

The analysis on greater than 1.8 million infections discovered just one,739 circumstances by which individuals examined optimistic for Covid-19 twice inside a two-month window. Of these, 47 had been BA.1 infections that had been adopted by BA.2.

When researchers seemed extra intently, they discovered that these kinds of reinfections tended to occur to younger and unvaccinated individuals, principally kids. And their signs tended to be gentle.

The research was posted as a preprint, which means that it has not but been scrutinized by exterior specialists and revealed in a medical journal.

BA.2 is exceedingly contagious. Some epidemiologists have said its primary replica quantity could also be as excessive as 12, which means every sick particular person infects a median of 12 others. That will put it on par with measles, which additionally spreads via the air. The essential replica quantity for BA.1 is estimated to be about 8.

In a preprint research from Sweden, researchers measured viral ranges in swabs from the again of the nasal cavity. They discovered practically twice as a lot viral RNA in samples from BA.2 sufferers than in those that examined optimistic for BA.1, “pointing to a considerable distinction in viral load.”

Advertisement

Viral hundreds had been about the identical for Delta and BA.1 infections, they stated, “whereas the rise in viral load in BA.2 circumstances was stunning.”

One other preprint research from Qatar picked up this distinction, too.

Laith Abu-Raddad, a professor of inhabitants sciences at Weill Cornell Medication-Qatar, has been learning the effectiveness of vaccines and boosters towards BA.1 and BA.2. A serious distinction between the 2 infections is an individual’s viral load, he stated.

“It’s positively method increased” with BA.2 over BA.1, he stated. His research discovered it to be “virtually 10-fold increased.”

As a substitute of going deeply into the lungs, the best way Delta did, the Omicron strains appear rather more targeted on the higher respiratory tract, the place the nostril meets the again of the throat, Abu-Raddad stated.

Advertisement

He thinks that as a result of the an infection concentrates there, that additionally helps it unfold effectively when individuals discuss, cough or sneeze.

Maybe one brilliant spot within the BA.2 image could also be severity.

Though research in animals have instructed that BA.2 an infection wasn’t totally gentle, knowledge on human infections from the UK, Denmark and South Africa reveals that BA.2 isn’t extra more likely to end in hospitalization in comparison with BA.1.

This week, the UK Well being Safety Company up to date its knowledge on vaccine effectiveness towards BA.2. As much as 14 weeks, boosters had been nonetheless 90% efficient at stopping extreme illness in individuals over the age of 65, pointing to an necessary method to ensure BA.2 doesn’t lay us low.

Advertisement

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

News

Read the Letter to the Inspectors General

Published

on

Read the Letter to the Inspectors General

Your investigation of these allegations is consistent with the IG’s mission to prevent waste, fraud, and abuse in federal agencies, and can help determine if politically connected crypto interests are undermining our national security. As Congress considers legislation on the market structure for digital assets, we must ensure that cryptocurrencies like USD1 are not providing the President and senior officials with the ability to line their pockets at the expense of the public interest.

The following facts have been reported in multiple outlets regarding Mr. Witkoff:

• Mr. Witkoff’s son Zach Witkoff is the CEO of World Liberty Financial (WLF), which the President’s family owns a majority stake in.³
• Beginning in January, one of Sheikh Tahnoon’s employees, Fiacc Larkin, joined WLF as the “chief strategic advisor” while continuing to work at G42, an AI investment firm owned by Sheikh Tahnoon that, according to the U.S. intelligence community, works closely with Chinese military companies.4



On May 1, 2025, Zach Witkoff announced that MGX, a state-owned investment firm controlled by Sheikh Tahnoon, had agreed to use a WLF-issued stablecoin, USD1, to make a $2 billion investment in Binance. As a result of this deal, WLF stands to reap hundreds of millions of dollars in transaction fees from MGX, and more from the returns on any investments it makes with the $2 billion deposit.³
As of August, Mr. Witkoff maintained a financial interest in WLF and thus stands to personally benefit from his son’s business dealings with the UAE.6 Nevertheless, he did not recuse himself from deliberations regarding the UAE, which may violate federal ethics law.

The following facts have been reported about Mr. Sacks:







He is a special government employee who continues to serve as a “general partner” at his venture capital fund, Craft Ventures.

8

The Abu Dhabi Investment Authority, an Emirati sovereign wealth fund controlled by Sheikh Tahnoon, was an early investor in Craft Ventures and continues to hold an investment in the fund.
In addition, Craft Ventures is invested in BitGo, which has partnered with WLF to provide the technical infrastructure for USD1. If BitGo’s valuation grows, based on the UAE’s investment into USD1, Mr. Sacks and his firm stand to benefit.

3 Yahoo Finance, “Trump family reportedly has a 60% stake in the World Liberty Financial,” Anand Sinha, March 31, 2025,
https://finance.yahoo.com/news/trump-family-reportedly-60-stake-172742661.html.
4 New York Times, “Inside U.S. Efforts to Untangle an A.I. Giant’s Ties to China,” Mark Mazzetti and Edward
Wong, Nov. 27, 2023, www.nytimes.com/2023/11/27/us/politics/ai-us-uae-china-security-g42.html.
5 New York Times, “At a Dubai Conference, Trump’s Conflicts Take Center Stage,” David Yaffe-Bellany, May 1, 2025, https://www.nytimes.com/2025/05/01/us/politics/trump-cryptocurrency-usd1-dubai-conference-

announcement.html.

6U.S Office of Government Ethics, Form 278e for Steven C. Witkoff, August 13, 2025, p. 23, https://static01.nyt.com/newsgraphics/documenttools/090d0de07e1d2fdf/bbf02867-full.pdf.

18 U.S.C. § 208.

8 White House, “Limited Waiver Pursuant to 18 U.S.C. § 208(b)(1) Regarding A.I. Assets,” June 2025,
https://www.whitehouse.gov/wp-content/uploads/2025/06/David-Sacks.pdf.

2

Continue Reading

News

Farage refuses to criticise Trump over paracetamol despite health experts dismissing autism claims

Published

on

Farage refuses to criticise Trump over paracetamol despite health experts dismissing autism claims

Nigel Farage has refused to criticise Donald Trump’s claims that paracetamol, sold in the US as Tylenol, could cause autism, insisting “science is never settled” and he would never “side with” medical experts.

The Reform UK leader said he had “no idea” if the US president was right to tell pregnant women to avoid taking acetaminophen, also known as Tylenol and paracetamol, and suggesting that those who could not “tough it out” should limit their intake.

Scientists and global health agencies including the World Health Organization have strongly dismissed Trump’s false claims, calling them misguided and saying the evidence linking paracetamol use in pregnancy and autism was “inconsistent”.

The UK’s health secretary, Wes Streeting, told the British public they should not “pay any attention whatsoever to what Donald Trump says about medicine”, adding: “I trust doctors over President Trump frankly, on this.”

But in a wide-ranging interview with LBC’s Nick Ferrari, Farage was asked directly if Trump was right to share those unproven claims. He said: “I have no idea, I’ve no idea. You know we were told thalidomide was a very safe drug and it wasn’t. Who knows Nick, I don’t know.

Advertisement

“He [Trump] has a particular thing about autism. I think because there’s been some in his family, he feels it very personally. I’ve no idea.”

When Farage was asked if he would side with medical experts who say it is dangerous to make the link, he added: “I wouldn’t. I wouldn’t. When it comes to science, I don’t side with anybody, right? You know? I don’t side with anybody, because science is never settled. We should remember that.”

Yet when challenged over whether it was irresponsible for Trump to make such an unproven claim, Farage said: “That’s an opinion he’s [Trump’s] got. It’s not one that I necessarily share.”

Farage’s refusal to condemn Trump’s claims comes weeks after a controversial doctor, Aseem Malhotra, was given top billing at Reform UK’s party conference and used his main-stage speech to claim the Covid vaccine caused cancer in the royal family. Malhotra is an adviser to Trump’s health secretary, Robert F Kennedy.

In the same interview, Farage said Trump was “right to say” that sharia law “is an issue in London”.

Advertisement

“Never take what he [Trump] says literally, ever on anything. But always take everything he says seriously,” Farage said, adding: Trump “has a point.”

“So is he right to say that sharia is an issue in London? Yes. Is it an overwhelming issue at this stage? No. Has the mayor of London directly linked himself to it? No.”

Labour MPs have urged Keir Starmer to reprimand Trump’s administration after the US president falsely claimed in a speech to the United Nations: “I look at London, where you have a terrible mayor, terrible, terrible mayor, and it’s been changed, it’s been so changed.

skip past newsletter promotion

“Now they want to go to sharia law. But you are in a different country, you can’t do that.”

Trump has been publicly attacking the London mayor, Sadiq Khan, since 2015 when the Labour politician criticised Trump, the then presidential candidate, for suggesting that Muslims should be banned from travelling to the US.

A spokesperson for Khan said: “We are not going to dignify his appalling and bigoted comments with a response. London is the greatest city in the world, safer than major US cities and we’re delighted to welcome the record number of US citizens moving here.”

During the LBC phone-in, Farage also said Reform’s plan to ban anyone who was not a UK citizen from claiming benefits would not apply to Ukrainians and Hongkongers.

Advertisement

“No, because they come for different reasons,” Farage said, adding those who had lived in the UK on indefinite leave to remain and had not worked or paid into the system would be told their benefits would be cut.

Continue Reading

News

Alphabet market value exceeds $3tn

Published

on

Alphabet market value exceeds tn

Unlock the Editor’s Digest for free

Alphabet’s market capitalisation surged above $3tn for the first time on Monday on the back of a sharp rally for the search giant’s shares over the past few weeks.

Shares in Google’s parent company have climbed more than 30 per cent to a record high of $252 since the group posted double-digit growth in revenue and profit in quarterly results out in late July.

The rally means Alphabet joins Nvidia, Microsoft and Apple as the only US companies valued above $3tn. Chipmaker Nvidia in July became the first company to hit a $4tn market value.

Advertisement

This is a developing story

Continue Reading
Advertisement

Trending